
Ralph J. Gitomer
Examiner (ID: 8603, Phone: (571)272-0916 , Office: P/1657 )
| Most Active Art Unit | 1657 |
| Art Unit(s) | 1622, 1815, 1803, 1211, 1651, 1657, 1655, 1627, 1623, 2899 |
| Total Applications | 3335 |
| Issued Applications | 2109 |
| Pending Applications | 286 |
| Abandoned Applications | 943 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6632024
[patent_doc_number] => 20100173339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'PLATELET ACTIVATION MARKERS AS INDICATORS FOR ANTI-PLATELET THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/728760
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9546
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728760 | PLATELET ACTIVATION MARKERS AS INDICATORS FOR ANTI-PLATELET THERAPY | Mar 21, 2010 | Abandoned |
Array
(
[id] => 8152140
[patent_doc_number] => 08168626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Benzodiazepine compositions for treating epidermal hyperplasia and related disorders'
[patent_app_type] => utility
[patent_app_number] => 12/728716
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 10
[patent_no_of_words] => 38765
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168626.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728716 | Benzodiazepine compositions for treating epidermal hyperplasia and related disorders | Mar 21, 2010 | Issued |
Array
(
[id] => 6294735
[patent_doc_number] => 20100240082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'METHODS FOR DETECTING AND MEASURING POLYSACCHARIDE-HYDROLYZING ENZYMES'
[patent_app_type] => utility
[patent_app_number] => 12/726424
[patent_app_country] => US
[patent_app_date] => 2010-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10415
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240082.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726424 | METHODS FOR DETECTING AND MEASURING POLYSACCHARIDE-HYDROLYZING ENZYMES | Mar 17, 2010 | Abandoned |
Array
(
[id] => 6499538
[patent_doc_number] => 20100209949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'LUMINESCENCE MEASUREMENT METHOD AND LUMINESCENCE MEASUREMENT SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/725878
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16122
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209949.pdf
[firstpage_image] =>[orig_patent_app_number] => 12725878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/725878 | Luminescence measurement system | Mar 16, 2010 | Issued |
Array
(
[id] => 6327872
[patent_doc_number] => 20100197707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Platelet manipulation to reduce the incidence of and treat endovascular disease and its sequelae, to reduce the incidence of and treat arrhythmias and to reduce the incidence of malignancy'
[patent_app_type] => utility
[patent_app_number] => 12/724602
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19096
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197707.pdf
[firstpage_image] =>[orig_patent_app_number] => 12724602
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724602 | Method of treating vascular disease | Mar 15, 2010 | Issued |
Array
(
[id] => 6428670
[patent_doc_number] => 20100168401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes'
[patent_app_type] => utility
[patent_app_number] => 12/659378
[patent_app_country] => US
[patent_app_date] => 2010-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 12591
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168401.pdf
[firstpage_image] =>[orig_patent_app_number] => 12659378
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/659378 | Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes | Mar 7, 2010 | Abandoned |
Array
(
[id] => 6552864
[patent_doc_number] => 20100222657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Method for glucose monitoring using fluorescence quenching'
[patent_app_type] => utility
[patent_app_number] => 12/660884
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7654
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222657.pdf
[firstpage_image] =>[orig_patent_app_number] => 12660884
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/660884 | Method for glucose monitoring using fluorescence quenching | Mar 4, 2010 | Issued |
Array
(
[id] => 6196086
[patent_doc_number] => 20110027844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'METHOD FOR PRODUCING QUINONES'
[patent_app_type] => utility
[patent_app_number] => 12/716933
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6190
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027844.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716933
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716933 | METHOD FOR PRODUCING QUINONES | Mar 2, 2010 | Abandoned |
Array
(
[id] => 4545620
[patent_doc_number] => 07960138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine'
[patent_app_type] => utility
[patent_app_number] => 12/715627
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11799
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12715627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/715627 | Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | Mar 1, 2010 | Issued |
Array
(
[id] => 5936677
[patent_doc_number] => 20110212461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'PREDICTION OF CARDIOTOXICITY'
[patent_app_type] => utility
[patent_app_number] => 12/713976
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3183
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212461.pdf
[firstpage_image] =>[orig_patent_app_number] => 12713976
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/713976 | PREDICTION OF CARDIOTOXICITY | Feb 25, 2010 | Abandoned |
Array
(
[id] => 6134879
[patent_doc_number] => 20110008765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'USE OF THREE-DIMENSIONAL MICROFABRICATED TISSUE ENGINEERED SYSTEMS FOR PHARMACOLOGIC APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/707469
[patent_app_country] => US
[patent_app_date] => 2010-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 33748
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12707469
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/707469 | Method of determining metabolism of a test agent | Feb 16, 2010 | Issued |
Array
(
[id] => 6538157
[patent_doc_number] => 20100221727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'SITE-SPECIFIC ENZYMATIC DEPOSITION OF METAL IN SITU'
[patent_app_type] => utility
[patent_app_number] => 12/707575
[patent_app_country] => US
[patent_app_date] => 2010-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25597
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12707575
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/707575 | Kit for enzymatic deposition of a metal | Feb 16, 2010 | Issued |
Array
(
[id] => 7977163
[patent_doc_number] => 08071328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Bioluminescent protease assay'
[patent_app_type] => utility
[patent_app_number] => 12/706078
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 13
[patent_no_of_words] => 9261
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071328.pdf
[firstpage_image] =>[orig_patent_app_number] => 12706078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/706078 | Bioluminescent protease assay | Feb 15, 2010 | Issued |
Array
(
[id] => 7651302
[patent_doc_number] => 20110300571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Determination of the Liver Toxicity of an Agent'
[patent_app_type] => utility
[patent_app_number] => 13/148082
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11933
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300571.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148082
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148082 | Determining liver toxicity of an agent using metabolite biomarkers | Feb 4, 2010 | Issued |
Array
(
[id] => 6436586
[patent_doc_number] => 20100143930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Biological indicator'
[patent_app_type] => utility
[patent_app_number] => 12/658350
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6908
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143930.pdf
[firstpage_image] =>[orig_patent_app_number] => 12658350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/658350 | Biological indicator | Feb 4, 2010 | Issued |
Array
(
[id] => 8005693
[patent_doc_number] => 08084247
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Biological indicator'
[patent_app_type] => utility
[patent_app_number] => 12/658214
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6918
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084247.pdf
[firstpage_image] =>[orig_patent_app_number] => 12658214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/658214 | Biological indicator | Feb 3, 2010 | Issued |
Array
(
[id] => 6426563
[patent_doc_number] => 20100151562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Biological indicator'
[patent_app_type] => utility
[patent_app_number] => 12/658213
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6907
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151562.pdf
[firstpage_image] =>[orig_patent_app_number] => 12658213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/658213 | Biological indicator | Feb 3, 2010 | Issued |
Array
(
[id] => 8457827
[patent_doc_number] => 08293493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-23
[patent_title] => 'Thrombin generation determination method'
[patent_app_type] => utility
[patent_app_number] => 12/694318
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1800
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12694318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694318 | Thrombin generation determination method | Jan 26, 2010 | Issued |
Array
(
[id] => 7755700
[patent_doc_number] => 20120028331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'ENZYMATIC REACTION REAGENT, ENZYMATIC REACTION REAGENT KIT AND METHOD FOR STORING LIQUID FOR ENZYMATIC REACTION'
[patent_app_type] => utility
[patent_app_number] => 13/201162
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5207
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028331.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201162
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201162 | ENZYMATIC REACTION REAGENT, ENZYMATIC REACTION REAGENT KIT AND METHOD FOR STORING LIQUID FOR ENZYMATIC REACTION | Jan 24, 2010 | Abandoned |
Array
(
[id] => 4431701
[patent_doc_number] => 07968326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Removal of by-products from crosslinkable preparations'
[patent_app_type] => utility
[patent_app_number] => 12/691421
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6746
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12691421
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/691421 | Removal of by-products from crosslinkable preparations | Jan 20, 2010 | Issued |